About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:2663596
Allelic
Composition
Epas1tm1Pec/Epas1tm1Pec
Genetic
Background
involves: 129/Sv * Swiss
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Epas1tm1Pec mutation (0 available); any Epas1 mutation (66 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• newborn homozygotes die within 2-3 hours of life due to severe respiratory failure (J:77480)
• homozygous mutants surviving embryogenesis die at birth (J:83549)
• half of homozygous mutant embryos die during gestation
• at E13.5, half of mutant embryos die of cardiac failure

homeostasis/metabolism
• newborn homozygotes display cyanosis

respiratory system
• at E18.5, a small deficit in vascularization of saccular septa is observed, as determined by the number of vessels/sacculus
• unlike in newborn wild-type mice where capillaries are juxtaposed to the lumen in ~95% of terminal sacs, mutant capillaries lay more distant from the lumen in ~30% of terminal sacs
• however, basement membrane formation of microvessels in the septa is normal and branching of large pulmonary vessels is unaffected
• at birth, thinning of the alveolar septa is impaired due to defective epithelial differentiation
• unlike in wild-type lungs, immature PAS+ (glycogen-rich) epithelial cells fail to progressively disappear after E18.5
• at >E16.5, pulmonary VEGF protein levels increased by ~4-fold in wild-type fetuses, but only minimally in mutant fetuses
• in mutant neonates, pulmonary VEGF transcript levels are reduced by ~30% in type II pneumocytes
• epithelial cell differentiation is impaired; abundant immature PAS+ (glycogen-rich) epithelial cells are shown to persist after E18.5, unlike in wild-type lungs
• however, no differences in epithelial cell proliferation or apoptosis are observed
• lamellar bodies persist in the alveolar lumen and fail to form myelin structures and a surfactant layer, unlike in wild-type lungs where surfactant lamellar bodies are found inside type II pneumocytes
• in newborn homozygotes, the number of surfactant protein-B (SP-B) and SP-D positive type II pneumocytes is decreased relative to that in wild-type controls
• lung aeration (percentage of total surface filled with air) fails to increase after birth
• a significantly increased alveolar septal thickness is noted at E18.5 and at birth
• newborn homozygotes breath irregularly and display gasping and signs of retraction
• not due to growth retardation, respiratory muscle dysfunction, lung hypoplasia, impaired fluid clearance, hypoxic stress or other organ defects
• newborn homozygotes display severe respiratory failure due to extensive lung collapse
• newborn homozygotes produce less surfactant phospholipids and less SP-A, SP-B and SP-D than wild-type controls

cardiovascular system
• at E18.5, a small deficit in vascularization of saccular septa is observed, as determined by the number of vessels/sacculus
• unlike in newborn wild-type mice where capillaries are juxtaposed to the lumen in ~95% of terminal sacs, mutant capillaries lay more distant from the lumen in ~30% of terminal sacs
• however, basement membrane formation of microvessels in the septa is normal and branching of large pulmonary vessels is unaffected
• at E18.5, pulmonary angiogenesis is impaired as capillaries in the saccular septa fail to remodel properly

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
newborn respiratory distress syndrome DOID:12716 OMIM:267450
J:77480


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory